RxDoctor Payments Data

Andrew Styperek, MD

Procedural Dermatology · Tamarac, FLNPI 1528385507

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $637, 5.2 times the $122 reported in 2019.

$1,986in general payments, 2019–2025

Across 84 payments — averaging $23.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$474
  • Bard Peripheral Vascular, Inc.$144
  • Sun Pharmaceutical Industries Inc.$119
  • Johnson & Johnson$109
  • Galderma Laboratories, L.p.$100
  • Regeneron Healthcare Solutions, Inc.$97
  • plus $944 from 22 others

What the payments were for

  • Food & beverage$1,986100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,986 in reported general payments places this provider in the 55th percentile of 60 procedural dermatology providers in Florida.

See all procedural dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$1,608,361
Medicare patients
1,057
Services billed
3,708

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Minocycline Hcl1,937$10,353
Gentamicin Sulfate119$4,631
Ciprofloxacin Hcl285$1,367
Ketoconazole20$376
Clindamycin Hcl73$291
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$216
Cephalexin27$196
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$186
Mupirocin21$178
Tramadol Hcl59$124
ErythromycinErythromycin Base11$120
Celecoxib15$84
Oxycodone Hcl14$40
Gabapentin15$19

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Tamarac

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →